Amogh Boloor

Title: **Amogh Boloor: Innovator in Cytokine Modulation**

Introduction

Amogh Boloor is a prominent inventor residing in South San Francisco, California. He has made significant contributions in the field of biochemistry, specifically focusing on the modulation of cytokine activity, which plays a crucial role in inflammatory processes.

Latest Patents

Boloor holds one patent titled "Sulfonimidamide compounds as inhibitors of interleukin-1 activity." This patent relates to novel sulfonimidamide compounds and their potential use in treating disorders linked to the modulation of cytokines such as IL-1β and IL-18. The invention also emphasizes the modulation of NLRP3 and the inhibition of its activation as a means to influence inflammatory responses.

Career Highlights

Currently, Amogh Boloor is employed at Genentech, Inc., a leading biotechnology company known for its innovative therapies. His work at Genentech highlights his dedication to advancing medical research and developing impactful treatments for various inflammatory disorders.

Collaborations

During his career, Boloor has collaborated with notable colleagues, including Christopher McBride and Lynnie Lin Trzoss. These partnerships reflect the collaborative spirit prevalent in research-driven environments, enabling the exchange of ideas and knowledge among experts in the field.

Conclusion

Amogh Boloor's contributions to the field of cytokine modulation are notable within the biomedical research community. His patented innovations have the potential to lead to significant breakthroughs in treating inflammatory disorders, showcasing his impact as an inventor and a valuable member of the scientific community.